Why the study?
Does a machine learning-based model improve major adverse cardiac event prediction in patients with hypertrophic cardiomyopathy?
Population
Patients with hypertrophic cardiomyopathy
Key result
A machine learning model using clinical, genetic, echo, and MRI data demonstrated good performance for predicting major adverse cardiac events in patients with hypertrophic cardiomyopathy.
Authors
Loading...
Should not yet change hypertrophic cardiomyopathy practice; leaves open the value of multimodal machine learning models pending validation.
Does a machine learning-based model improve major adverse cardiac event prediction in patients with hypertrophic cardiomyopathy?
A machine learning model integrating multimodal data (clinical, genetic, and imaging) shows promise for predicting major adverse cardiac events in patients with hypertrophic cardiomyopathy.
Geyer et al. (2026) studied this question. A machine learning model using clinical, genetic, echo, and MRI data demonstrated good performance for predicting major adverse cardiac events in patients with hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: